University Of Vermont Medical Center
Clinical trials sponsored by University Of Vermont Medical Center, explained in plain language.
-
Could a 2-Week radiation course replace longer treatment for skin cancer?
Disease control Recruiting nowThis study tests whether a short course of radiation (5 treatments over 2 weeks) can prevent cancer from coming back in people with high-risk head and neck skin cancer after surgery. For those with moderate-risk cancer, researchers want to see if simply monitoring them closely is…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Brain tumor patients may avoid radiation thanks to smart drug strategy
Disease control Recruiting nowThis study is testing whether people with brain metastases (cancer that spread to the brain) can safely avoid radiation therapy if their cancer medication is working. About 45 adults with solid tumors, mostly non-small cell lung cancer, will start or continue systemic therapy (im…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
Can a simple blood thinner keep brain tumor patients safe from clots?
Prevention Recruiting nowThis study is testing whether the blood thinner apixaban can safely prevent blood clots in people newly diagnosed with a fast-growing brain tumor called grade 4 glioma. About 40 adults will take apixaban while receiving standard radiation and chemotherapy. The main goal is to see…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Prevention
Last updated Jun 23, 2026 12:00 UTC
-
New radiation method aims to ease gut pain for cancer patients
Symptom relief Recruiting nowThis study tests a new way of giving palliative radiation (HART) to people with metastatic cancer. The goal is to see if it causes fewer stomach and bowel side effects than standard radiation. About 103 adults with cancer that has spread will receive HART to bones or soft tissues…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 23, 2026 12:00 UTC
-
Tablet videos aim to ease cancer care confusion for rural vermonters
Symptom relief Recruiting nowThis study tests whether a tablet-based video program can help rural cancer patients better understand their care and feel more coordinated. About 40 adults with early-stage breast, lung, or colon cancer living in rural Vermont will be randomly assigned to receive the videos righ…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 22, 2026 11:59 UTC
-
Could a nerve drug ease Parkinson's gut troubles?
Symptom relief Recruiting nowThis study tests whether pyridostigmine, a drug that stimulates the gut, can safely relieve chronic constipation in people with Parkinson's disease. Constipation is a common and bothersome symptom that often appears years before movement problems. Sixteen adults with Parkinson's …
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:51 UTC
-
Eating right before cancer therapy: could it boost treatment success?
Symptom relief Recruiting nowThis study tests whether remote nutritional counseling helps cancer patients stick to their treatment plan and feel better. 240 adults with invasive cancer starting therapy will receive either a single consultation with written materials or a more intensive program with monthly f…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:28 UTC
-
Can coordinated care ease the burden of brain metastases?
Symptom relief Recruiting nowThis study compares intensive multi-disciplinary care (a team of specialists working together) to standard care for 40 adults with newly diagnosed brain metastases from solid tumors. The goal is to see if the team approach reduces symptom burden and helps patients better understa…
Phase: NA • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:26 UTC